Sanborn Kilcollin Partners’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$7.88M Sell
82,100
-42,772
-34% -$3.87M 5.51% 10
2014
Q2
$11.4M Buy
124,872
+1,007
+0.8% +$90.2K 5.26% 10
2014
Q1
$10.9M Buy
123,865
+5,920
+5% +$520K 5.5% 9
2013
Q4
$10.9M Sell
117,945
-7,851
-6% -$707K 5.7% 7
2013
Q3
$10.3M Buy
125,796
+10,615
+9% +$896K 5.42% 8
2013
Q2
$9.58M Buy
+115,181
New +$9.91M 5.82% 8

Other funds holding CLX

Sanborn Kilcollin Partners's CLX Position: Q3 2014 in Review

Sanborn Kilcollin Partners reduced its Clorox (CLX) stake by 34% in Q3 2014, selling an estimated $3.87M and leaving 82,100 shares worth $7.88M. The position accounts for 5.51% of the portfolio, ranked #10.

Sanborn Kilcollin Partners first reported a position in CLX in Q2 2013 and has held it in 6 quarters since. The position peaked at $11.4M in Q2 2014. 675 funds tracked by Wall St. Rank hold CLX as of Q3 2014.

  • Sanborn Kilcollin Partners held 82,100 shares of Clorox worth $7.88M as of Q3 2014.
  • Sanborn Kilcollin Partners sold 42,772 Clorox shares in Q3 2014, an estimated $3.87M.
  • Clorox made up 5.51% of Sanborn Kilcollin Partners's portfolio in Q3 2014, its #10 holding.
  • Sanborn Kilcollin Partners first reported a position in Clorox in Q2 2013 and has held it in 6 quarters since.
  • Sanborn Kilcollin Partners's Clorox position peaked at $11.4M in Q2 2014.
  • 675 funds tracked by Wall St. Rank held Clorox as of Q3 2014.

Based on Sanborn Kilcollin Partners's 13F filing for Q3 2014, filed 13 Nov 2014.